Skip to main content

Table 4 Ongoing clinical trials using adoptive cell therapy in breast cancer patients

From: Mechanisms of immune evasion in breast cancer

Patient population Intervention Phase Country NIH No
Metastatic breast cancer refractory to at least 1 standard therapy cMet CAR RNA T Cells Targeting Breast Cancer I USA NCT01837602
Malignant pleural disease, Mesothelioma, Lung Cancer, Breast Cancer Autologous T Cells Genetically Engineered to Target the Cancer-Cell Surface Antigen Mesothelin I USA NCT02414269
Solid tumors Tumor Associated Antigen (TAA)-Specific Cytotoxic T-Lymphocytes I USA NCT02239861